Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
biopharma
5 things to know in life sciences: Week of Oct. 12, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Oct. 5, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
SEC-FDA agreement: What life sciences leaders should know
The SEC/FDA agreement should prompt life sciences leadership teams and boards to confirm that their regulatory communications, public disclosures and financial reporting assumptions are aligned. … READ MORE >
5 things to know in life sciences: Week of Sept. 28, 2026
FDA backs new home monitoring technologies to reduce readmissions. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Sept. 21, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Sept. 14, 2026
FDA launches pilot to accelerate early-stage drug development. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Sept. 7, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Insights from FDA complete response letters: Preventing costly drug approval delays
FDA’s complete response letters reveal the importance of addressing issues early for biopharma companies. … READ MORE >
5 things to know in life sciences: Week of Aug. 24, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >